Suraksha Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suraksha Diagnostic Limited has informed the stock exchanges that the trading window for dealing in its securities will be closed from Wednesday, October 1, 2025, until 48 hours after the declaration of its unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2025. The closure applies to all designated persons and their immediate relatives, as mandated under SEBI's Insider Trading Regulations. The company has stated that the date of the board meeting to approve these Q2/H1 FY26 results will be communicated separately. The intimation was signed by Mamta Jain, Company Secretary and Compliance Officer.
This is a routine compliance filing with no direct impact on shareholders. However, it signals that Suraksha Diagnostic's Q2 and first-half FY26 earnings are likely to be announced in early-to-mid October 2025, which investors should watch as a potential stock price catalyst.